Compared to Estimates, C3.ai (AI) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 09/10/26
C3.ai Stock Has Plummeted by 22% in 2026. Buy the Dip, or Run for the Hills?The Motley Fool • 09/09/26
C3.ai vs. Intuit: Which Software Stock Is a Better Investment in 2026 as Both Hover Near 52-Week Lows?The Motley Fool • 08/30/26
C3.ai vs. UiPath: Which Artificial Intelligence Stock Is a Better Investment in 2026?The Motley Fool • 08/29/26
Seeking Clues to C3.ai (AI) Q1 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 08/28/26
C3.ai vs. Oracle: Which Artificial Intelligence Stock Is a Better Investment in 2026?The Motley Fool • 08/27/26
C3.ai, Inc. (AI) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 08/24/26
C3 AI to Announce Financial Results for Fiscal First Quarter 2027 on September 2, 2026Business Wire • 08/20/26
C3.ai vs. Seagate Technology: Which Technology Stock Is a Better Buy in 2026?The Motley Fool • 08/19/26
C3.ai vs. Lumentum: What Recent Revenue Trajectories Tell Investors About These Artificial Intelligence CompaniesThe Motley Fool • 08/19/26
Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical DevelopmentBusiness Wire • 08/18/26